Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
about
Drug-induced reactivation of apoptosis abrogates HIV-1 infectionPlacental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentIron metabolism and the innate immune response to infectionToward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniaeDrug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory TrialTranslational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3.Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteomeAdvances in iron chelation: an update.A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9Hepcidin induces HIV-1 transcription inhibited by ferroportinA hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancerPhenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcriptionEssential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development.In vitro anti-HIV-1 activity of salicylidene acylhydrazide compoundsDevelopment of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayers.Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cellsReversible Folding of a β-Hairpin Peptide by a Metal-Chelating Amino Acid.The translation factor eIF5A and human cancer.Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.Current status of the polyamine research fieldRole of cellular iron and oxygen in the regulation of HIV-1 infection.Global quantitative proteomics reveal up-regulation of endoplasmic reticulum stress response proteins upon depletion of eIF5A in HeLa cells.Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication.Lentiviral Nef suppresses iron uptake in a strain specific manner through inhibition of Transferrin endocytosis.Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents.Roles of eukaryotic initiation factor 5A2 in human cancer.HIV-1 replication and latency are regulated by translational control of cyclin T1A new non-radioactive deoxyhypusine synthase assay adaptable to high throughput screening.Iron overload down-regulates the expression of the HIV-1 Rev cofactor eIF5A in infected T lymphocytes.Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.The spermidine analogue GC7 (N1-guanyl-1,7-diamineoheptane) induces autophagy through a mechanism not involving the hypusination of eIF5A.Pokeweed antiviral protein alters splicing of HIV-1 RNAs, resulting in reduced virus production.Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.Polyamines and Their Role in Virus Infection.Regulation of gene expression by translation factor eIF5A: Hypusine-modified eIF5A enhances nonsense-mediated mRNA decay in human cells.Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology.In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria.Hypusination of eIF5A as a Target for Antiviral Therapy.
P2860
Q21090718-92A70361-7598-4589-B43E-A4310FBF5EB1Q26766128-2FD8C5CC-C549-4E21-A0F4-D62CC091A92EQ26860448-47A582D8-2EE4-498F-A50D-5868B1DCC07EQ28534775-C83CA144-CD07-4C3A-98D1-46FDF1719E38Q28552171-46A4F1F5-E1EF-4FDD-AB7B-5FB2DA145F1BQ33832420-E5752F90-2ECE-400F-BC23-C1C0A6595005Q34035345-A8B6DE19-D7A5-4EEA-B73A-1958C1FD7491Q34174307-42CA6572-05A9-4CB1-85DF-D51F36DCE255Q34206132-F278AC72-9FE7-4E01-9131-3031B8D6C4FCQ34407398-DC332E1E-E5E6-4C16-86D4-6F5A6FD4AD63Q34458484-E6644BC3-094D-4C64-B940-519ECEE47F9BQ34499129-018BB4D6-D6E9-4D8E-B305-EAE4A21D5DF8Q34518559-701AC82A-A74D-42BB-89D0-D6B3AB4A0E39Q34596398-C3FC4C53-286A-4F01-96F0-5A54EAF92EAFQ35563868-78E65548-C97C-4F13-B74C-3124F75BA2CDQ36223323-B8423648-BFC0-4DF5-B133-AF22BC726342Q36278270-B50F0B8B-891B-41B0-B9BD-306B76E251D0Q36318823-75136A2A-2F84-462D-8E20-ABAFA3B86C8FQ36332528-CB4AC084-3FDA-4CBD-B10D-D900B70A6772Q36519353-DAA5F422-0493-4632-997F-EC9521B52F79Q36557053-2C516EDF-8311-44E5-85E5-7EFB784922D3Q36838564-194CC531-C8E3-4276-A8A7-36CE436B1B57Q36839068-779B8B33-266E-4177-804D-031DC8ADAABDQ36903031-E439C7C6-F1C7-4ECD-B479-9DC923656974Q37168685-C75CBDE6-2E28-4EED-BC17-E727B6D26DF6Q37479957-B55842E4-36FD-42AD-AE13-5B134D14E5C1Q37991390-0A8150A3-E2D6-4DAE-948A-47F16E005100Q38163977-F146086E-89E8-4F86-9131-9D90A55F92CEQ38273477-3D9F0997-7164-4379-ABAD-6E0AD3DCB6E4Q38618845-E9565B97-E271-4D84-ABAA-BEB8FF25F6CDQ38635966-8A80BBF1-A9E4-4A29-B080-FEADE5798DDFQ38662748-BC3C546D-BF0B-4433-ABC5-F02D3995D608Q38956908-3F06BBCD-93A1-4253-A1B7-2AF29E4D87FCQ38982524-41B3994F-B2B9-4E67-A8AA-ECCF09C27B9EQ39795056-718DA8EC-ECB6-4BDE-8314-BEC8E7848B35Q40042584-442FC3E1-58A7-4E9C-BEA5-95B8C14E42FDQ42778157-63764EEB-4268-4647-BD6C-04B7782D8228Q54232255-8B94708F-A3C7-4D9A-9737-A5A576F8639AQ54275190-9F756FC7-F10D-4F2F-8F78-69513DA83CC7Q54453351-17FE533D-DA42-4F04-BDE0-6764E6EA99A7
P2860
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@ast
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@en
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@nl
type
label
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@ast
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@en
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@nl
prefLabel
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@ast
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@en
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of HIV-1 gene expre ...... karyotic initiation factor 5A.
@en
P2093
Darlene D'Alliessi Gandolfi
Deepti Saxena
Hartmut M Hanauske-Abel
Mainul Hoque
Michael B Mathews
Myung Hee Park
Paul Palumbo
Tsafi Pe'ery
P2860
P2888
P356
10.1186/1742-4690-6-90
P577
2009-10-13T00:00:00Z
P5875
P6179
1029437208